Clinical trials are research studies conducted in an effort to improve overall patient health and care. Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition. Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.

A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.

A brief description of each phase:

• Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
• Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
• Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
• Phase IV: These studies monitor long-term side effects after the treatment has been marketed.

---

Clinical Trials data for Multiple Sclerosis is grouped into the following categories:-

• View by trial name
• View by drugs used in Multiple Sclerosis clinical trials

---

Clinical Trials by trial name
The format for each of the following is:

• The name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.
• followed by a list of drug/s, if any, used in the trial

ClinicalTrials.gov has listed the following trials for Multiple Sclerosis:

• Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate - This study is currently recruiting patients (Current: 05 Jan 2006) - Glatiramer Acetate
• Safety/Effectiveness of Adding Monthly Dexamethasone to Weekly Avonex for MS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS) - This study is currently recruiting patients (Current: 05 Jan 2006) - ABT-874/Human monoclonal antibody against IL-12
• Safety of RG2077 in Patients With Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - RG2077 (CTLA4-IgG4m)
• Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone - This study is no longer recruiting patients (Current: 05 Jan 2006)
• A Phase II Study Comparing Low- and High-Dose CAMPATH and High-Dose Rebif in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - CAMPATH/MABCAMPATH (alemtuzumab)
• Treatment of Multiple Sclerosis Using Over the Counter Inosine - This study is currently recruiting patients (Current: 05 Jan 2006) - Inosine
• Study Evaluating Mitoxantrone in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Mitoxantrone
• Combination Therapy in MS - This study is currently recruiting patients (Current: 05 Jan 2006) - Interferon beta 1-a,glatiramer acetate
• Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006) - Mitoxantrone
• A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Lamotrigine
• Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - Natalizumab
• Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Daclizumab
• Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Natalizumab
• AVONEX Combination Trial ACT - This study is no longer recruiting patients (Current: 05 Jan 2006) - Methotrexate,IV methylprednisolone
• Study Evaluating CCI-779 in Relapsing Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - CCI-779
• Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability - This study has been completed (Current: 05 Jan 2006) - ACTOS (Pioglitazone)
• Avonex (Interferon-Beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-Remitting MS - This study has been completed (Current: 05 Jan 2006) - Interferon-beta-1a (Avonex) plus methylprednisolone
• Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Cyclophosphamide (drug),Methylprednisolone (drug)
• MR Perfusion Imaging and Hypercapnia (Increased Carbon Dioxide) to Study New Blood Vessel Formation in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• The Effect of Sildenafil Citrate (Viagra (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients - This study is currently recruiting patients (Current: 05 Jan 2006)
• Rebif New Formulation in Relapsing Forms of Multiple Sclerosis (RMS) - This study is no longer recruiting patients (Current: 05 Jan 2006) - Interferon-beta-1a FBS-free/HSA-free
• Assessment of Patients with Multiple Sclerosis (MS) - This study is currently recruiting patients (Current: 05 Jan 2006)
• Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS) - This study is currently recruiting patients (Current: 05 Jan 2006)
• A 48-Week (24-Week Baseline Followed by a 24-Week Treatment) Phase II Pilot Study of the Tolerability and Effect/Efficacy of Subcutaneously Administered Insulin-Like Growth Factor-1 (rhIGF) (CEP-151) in Multiple Sclerosis (MS) Patients - This study has been completed (Current: 05 Jan 2006)
• Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS) - This study has been completed (Current: 05 Jan 2006) - CGP 77116
• Zenapax to Treat Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - Zenapax
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - immune globulin
• Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - copolymer 1
• A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - monoclonal antibody M-T412
• Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - standard gadolinium contrast
• Rolipram to Treat Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Rolipram
• Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - anti-thymocyte globulin,cyclophosphamide,filgrastim,prednisone
• Registry to Evaluate Novantrone (R) Effects in Worsening Multiple Sclerosis (RENEW) - This study is no longer recruiting patients (Current: 05 Jan 2006) - Novantrone(R) (mitoxantrone for injection concentrate)
• Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - cyclophosphamide,filgrastim,methylprednisolone
• Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - interferon beta 1a,methotrexate
• Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX Treatment, in Patients Presenting With a First Acute Demyelinating Event. - This study is not yet open for patient recruitment (Current: 05 Jan 2006) - interferon beta 1a,methotrexate,methylprednisolone
• Auditory Function in Patients With and Without Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Treatment of Multiple Sclerosis With Copaxone and Albuterol - This study is currently recruiting patients (Current: 05 Jan 2006) - Glatiramer acetate,Albuterol
• Improving Memory in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - donepezil,glucose
• Magnetic Resonance Imaging to Detect Brain Damage in Patients with Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Immunotherapy With BHT-3009 Alone or Combined With Atorvastatin in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Health Behavior Change in Chronic Disease Management - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Restoration of Walking in Multiple Sclerosis Using Treadmill Training - This study is currently recruiting patients (Current: 05 Jan 2006)
• Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - teriflunomide
• Modafinil in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Modafinil
• Stress Management for Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - escitalopram oxalate antidepressant
• Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients - This study is currently recruiting patients (Current: 05 Jan 2006) - estroprogestins,interferon-beta 1a
• Restoration of Walking in Multiple Sclerosis Using Treadmill Training. - This study is currently recruiting patients (Current: 05 Jan 2006)
• Treating New Learning in MS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Efficacy and Safety of BG00012 in MS - This study is no longer recruiting patients (Current: 05 Jan 2006) - BG00012
• Efficacy of 3,4-Diaminopyridine in MS Patients With Fatigue - This study is currently recruiting patients (Current: 05 Jan 2006) - 3,4 Diaminopyridine
• Phase IV, Rater-Blinded, Randomized Study, Comparing the Effects of 250 Mg of Betaseron With 20 Mg of Copaxone in Patients With the Relapsing-Remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-Dose Gadolinium - This study is no longer recruiting patients (Current: 05 Jan 2006) - Betaserone or Copaxone, MRI and Gadolinum
• Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - interferon beta 1a 30 ug IM once weekly
• Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - 3,4-diaminopyridine
• Gene Expression in MS Patients Before and During Treatment With Interferon-Beta - This study is currently recruiting patients (Current: 05 Jan 2006)
• Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Bacille of Calmette-Guerin
• Use of Cannabinoids in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Sativex
• A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - CNTO 1275
• Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• TCV -01-002 - This study is currently recruiting patients (Current: 05 Jan 2006)
• Infections and Autoimmunity - This study is currently recruiting patients (Current: 05 Jan 2006)
• Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis. - This study is no longer recruiting patients (Current: 05 Jan 2006) - FTY720
• Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Smoked Cannabis
• Cannabis for Spasticity in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Smoked Cannabis
• Simvastatin Treatment of Patients With Acute Optic Neuritis. - This study is not yet open for patient recruitment (Current: 05 Jan 2006) - simvastatin
• Interferon -1b Treatment by Cyclical Administration - This study is currently recruiting patients (Current: 05 Jan 2006) - Interferon-ß-1b
• Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity. - This study has been completed (Current: 05 Jan 2006) - tizanidine hydrochloride capsule
• A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Rituxan (rituximab)
• Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Atorvastatin
• A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - Rituxan (rituximab)
• A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Avonex and Topamax
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Daclizumab (Anti-CD25 Humanized Monoclonal Antibody)
• POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - nomegestrol acetate,estradiol
• Safety and Efficacy of Teriflunomide (HMR 1726) in Multiple Sclerosis With Relapses - This study is no longer recruiting patients (Current: 05 Jan 2006) - Teriflunomide
• Rebif Versus Copaxone in the Treatment of Relapsing Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - Human interferon beta-1a and glatiramer acetate
• Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects - This study has been terminated (Current: 05 Jan 2006) - Rebif
• Safety and Efficacy of Pravastatin in Relapsing-Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Pravastatin,Placebo
• A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone Compared to Copaxone 20mg, the Currently Approved Dose - This study is no longer recruiting patients (Current: 05 Jan 2006) - glatiramer acetate
• Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS - This study is currently recruiting patients (Current: 05 Jan 2006) - Glatiramer Acetate,Interferion Beta,Interferon Alpha
• Copaxone Study to Follow Patients From the First Original Study for Safety and Effectiveness. - This study is no longer recruiting patients (Current: 05 Jan 2006) - glatiramer acetate
• A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis. - This study has been completed (Current: 05 Jan 2006) - glatiramer acetate,mitoxantrone
• A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis - This study is not yet open for patient recruitment (Current: 05 Jan 2006) - glatiramer acetate,mitoxantrone
• Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine. - This study is currently recruiting patients (Current: 05 Jan 2006) - glatiramer acetate,N-acetylcysteine
• Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline - This study is currently recruiting patients (Current: 05 Jan 2006) - glatiramer acetate,minocycline
• Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS - This study is currently recruiting patients (Current: 05 Jan 2006) - Provigil (modafinil)
• A Study to Assess the Effects of MK-0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI. - This study is no longer recruiting patients (Current: 05 Jan 2006) - MK0812
• A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Simvastatin
• Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - Natalizumab
• BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose - This study is no longer recruiting patients (Current: 05 Jan 2006) - Betaseron/Betaferon 250mcg, Betaseron/Betaferon 500mcg and Copaxone
• BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose - This study is no longer recruiting patients (Current: 05 Jan 2006) - Betaseron/Betaferon 250mcg, Betaseron/Betaferon 500mcg and Copaxone
• An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-Remitting MS - This study has been terminated (Current: 05 Jan 2006) - Interferon Beta-1b
• Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Immune Globulin Intravenous (Human)
• Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron to Treat Relapsing-Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - Interferon beta-1b
• Autologous T Cell Vaccine (TCV) for Multiple Sclerosis - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Optic Neuritis Treatment Trial (ONTT) - This study is no longer recruiting patients (Current: 05 Jan 2006) - Methylprednisolone,Prednisone
• Longitudinal Optic Neuritis Study (LONS) - This study is no longer recruiting patients (Current: 05 Jan 2006) - Methylprednisolone,Prednisone
• Evaluation of Lyme Disease: Clinical, Microbiological and Immunological Characteristics - This study is currently recruiting patients (Current: 05 Jan 2006)
• Natural Antioxidants in the Treatment of Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Ginkgo biloba,Alpha-lipoic acid,Vitamin E/Selenium,Essential fatty acids
• Yoga: Effect on Attention in Aging & Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-Remitting Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006) - CTLA4Ig
• High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006) - Cyclophosphamide,ATG,MESNA
• Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Rifampin,Azithromycin
• Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients - This study is no longer recruiting patients (Current: 05 Jan 2006) - AVP-923
• Safety and Efficacy Study of Oral Fampridine-SR on Walking Ability in Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Fampridine-SR (4-aminopyridine, 4-AP)
• Safety Testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) - This study is currently recruiting patients (Current: 05 Jan 2006) - AVP-923
• Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS) - This study has been completed (Current: 05 Jan 2006) - NBI-5788
• Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor - This study has been completed (Current: 05 Jan 2006) - Sirolimus
• Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - SB683699
• A Study in Multiple Sclerosis Patients to Determine the Safety of Different Doses of RO0506997 Compared to Placebo and Their Effects on Multiple Sclerosis Lesions - This study is not yet open for patient recruitment (Current: 05 Jan 2006) - RO0506997
• Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Fish oil capsules
• Study of Oral Fampridine-SR in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Fampridine-SR (4-aminopyridine, 4-AP)
• EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Rebif/Lipitor
• A Multicenter, Open-Label Randomized Crossover Trial to Assess Subject Preference for Kemstro Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006) - Kemstro
• Effects of Spinal Cord Injury on Female Sexual Response - This study is currently recruiting patients (Current: 05 Jan 2006)
• EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Avonex/Zocor
• Follow-Up Study of the BENEFIT Study (Betaferon / Betaseron in Newly Emerging Multiple Sclerosis for Initial Treatment) - This study is no longer recruiting patients (Current: 05 Jan 2006) - Interferon beta-1b
• Multiple Sclerosis Rehabilitation Study - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia - This study is currently recruiting patients (Current: 05 Jan 2006) - Riluzole
• Betaseron 16-Year LTF - This study is currently recruiting patients (Current: 05 Jan 2006)
• Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006) - Mycophenolate Mofetil (cellcept)
• Cognitive Effects of Immunomodulatory Drugs in MS - This study is currently recruiting patients (Current: 05 Jan 2006)
• A Study to Evaluate Readiness to Self-Inject on Adherence and Compliance to Copaxone Therapy - This study has been completed (Current: 05 Jan 2006)
• A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone - This study has been completed (Current: 05 Jan 2006) - glatiramer acetate
• A Study Comparing Shared Solutions Plus MS Center Support Versus Shared Solutions Alone - This study is not yet open for patient recruitment (Current: 05 Jan 2006) - glatiramer acetate
• A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec) or Placebo Prior to Daily Injections of Copaxone. - This study is currently recruiting patients (Current: 05 Jan 2006) - Copaxone (glatiramer acetate injection),Zyrtec (cetirizine hydrochloride)
• Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006) - Doxycycline
• Prospective, Open-Label Tolerability and Safety Monitoring Study of Novantrone in a Selected Cohort of Multiple Sclerosis Patients - This study is no longer recruiting patients (Current: 05 Jan 2006)
• FOCUS Fatigue Outcome in Copaxone USers - This study is no longer recruiting patients (Current: 05 Jan 2006) - Glatiramer actetate
• Fatigue Treatment Using Provigil - This study is not yet open for patient recruitment (Current: 05 Jan 2006) - Provigil
• Sleep Disorders in Patients With Multiple Sclerosis (MS) - This study is currently recruiting patients (Current: 05 Jan 2006)

---

Drugs used in Clinical Trials for Multiple Sclerosis
The format for each of the following is:

• The drug,
• followed by the name of the trial,
• followed by whether the trial is recruiting patients,
  - The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
  - Note**: Please follow the link to determine the current trial status.

ClinicalTrials.gov has listed the following drugs in trials for Multiple Sclerosis:

• 3,4 Diaminopyridine - Efficacy of 3,4-Diaminopyridine in MS Patients With Fatigue - This study is currently recruiting patients (Current: 05 Jan 2006)
• 3,4-diaminopyridine - Efficacy of 3,4-DAP in Fatigue Associated With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• ABT-874/Human monoclonal antibody against IL-12 - Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS) - This study is currently recruiting patients (Current: 05 Jan 2006)
• ACTOS (Pioglitazone) - Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability - This study has been completed (Current: 05 Jan 2006)
• ATG - High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006)
• AVP-923 - Safety Testing of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Laughter & Crying) - This study is currently recruiting patients (Current: 05 Jan 2006)
• AVP-923 - Safety and Efficacy of AVP-923 for Pseudobulbar Affect in Multiple Sclerosis Patients - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Albuterol - Treatment of Multiple Sclerosis With Copaxone and Albuterol - This study is currently recruiting patients (Current: 05 Jan 2006)
• Alpha-lipoic acid - Natural Antioxidants in the Treatment of Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Anti-Thymocyte Globulin - Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Atorvastatin - Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Avonex and Topamax - A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Avonex/Zocor - EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Azithromycin - Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• BG00012 - Efficacy and Safety of BG00012 in MS - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Bacille of Calmette-Guerin - Efficacy of Anti-Tubercular Vaccination in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Betaseron/Betaferon 250mcg, Betaseron/Betaferon 500mcg and Copaxone - BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Betaseron/Betaferon 250mcg, Betaseron/Betaferon 500mcg and Copaxone - BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Betaserone or Copaxone, MRI and Gadolinum - Phase IV, Rater-Blinded, Randomized Study, Comparing the Effects of 250 Mg of Betaseron With 20 Mg of Copaxone in Patients With the Relapsing-Remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-Dose Gadolinium - This study is no longer recruiting patients (Current: 05 Jan 2006)
• CAMPATH/MABCAMPATH (alemtuzumab) - A Phase II Study Comparing Low- and High-Dose CAMPATH and High-Dose Rebif in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• CCI-779 - Study Evaluating CCI-779 in Relapsing Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• CGP 77116 - Safety, Tolerability, and Effectiveness of CGP77116 in Patients with Multiple Sclerosis (MS) - This study has been completed (Current: 05 Jan 2006)
• CNTO 1275 - A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• CTLA4Ig - A Study to Evaluate the Preliminary Efficacy Pharmacokinetics and Immunogenicity of BMS-188667 Administered to Subjects With Relapsing-Remitting Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006)
• Copaxone (glatiramer acetate injection) - A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec) or Placebo Prior to Daily Injections of Copaxone. - This study is currently recruiting patients (Current: 05 Jan 2006)
• Copolymer 1 - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Cyclophosphamide (drug) - Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Cyclophosphamide - High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006)
• Cyclophosphamide - Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Cyclophosphamide - Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Daclizumab (Anti-CD25 Humanized Monoclonal Antibody) - Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Daclizumab - Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Donepezil - Improving Memory in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Doxycycline - Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Escitalopram Oxalate Antidepressant - The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Essential fatty acids - Natural Antioxidants in the Treatment of Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Estradiol - POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Estroprogestins - Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients - This study is currently recruiting patients (Current: 05 Jan 2006)
• FTY720 - Extension Study to Evaluate Safety, Tolerability and Effects on Efficacy Parameters of FTY720 in Patients With Relapsing Multiple Sclerosis. - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Fampridine-SR (4-aminopyridine, 4-AP) - Safety and Efficacy Study of Oral Fampridine-SR on Walking Ability in Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Fampridine-SR (4-aminopyridine, 4-AP) - Study of Oral Fampridine-SR in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Filgrastim - Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Filgrastim - Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Fish oil capsules - Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Ginkgo biloba - Natural Antioxidants in the Treatment of Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Glatiramer Acetate - A Study Comparing Shared Solutions Plus MS Center Support Versus Shared Solutions Alone - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Glatiramer Acetate - A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone - This study has been completed (Current: 05 Jan 2006)
• Glatiramer Acetate - A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis. - This study has been completed (Current: 05 Jan 2006)
• Glatiramer Acetate - A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Glatiramer Acetate - A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone Compared to Copaxone 20mg, the Currently Approved Dose - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Glatiramer Acetate - Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate - This study is currently recruiting patients (Current: 05 Jan 2006)
• Glatiramer Acetate - Combination Therapy in MS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Glatiramer Acetate - Copaxone Study to Follow Patients From the First Original Study for Safety and Effectiveness. - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Glatiramer Acetate - Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Glatiramer Acetate - Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline - This study is currently recruiting patients (Current: 05 Jan 2006)
• Glatiramer Acetate - Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine. - This study is currently recruiting patients (Current: 05 Jan 2006)
• Glatiramer acetate - Treatment of Multiple Sclerosis With Copaxone and Albuterol - This study is currently recruiting patients (Current: 05 Jan 2006)
• Glatiramer actetate - FOCUS Fatigue Outcome in Copaxone USers - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Glucose - Improving Memory in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Human interferon beta-1a and glatiramer acetate - Rebif Versus Copaxone in the Treatment of Relapsing Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• IV methylprednisolone - AVONEX Combination Trial ACT - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Immune Globulin Intravenous (Human) - Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Immune Globulin - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Inosine - Treatment of Multiple Sclerosis Using Over the Counter Inosine - This study is currently recruiting patients (Current: 05 Jan 2006)
• Interferion Beta - Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Interferon Alpha - Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Interferon Beta 1A 30 Ug Im Once Weekly - Long Term Study of Avonex Therapy Following a First Attack of Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Interferon Beta 1A - Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Interferon Beta 1A - Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX Treatment, in Patients Presenting With a First Acute Demyelinating Event. - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Interferon Beta-1b - An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-Remitting MS - This study has been terminated (Current: 05 Jan 2006)
• Interferon beta 1-a - Combination Therapy in MS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Interferon beta-1b - Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron to Treat Relapsing-Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Interferon beta-1b - Follow-Up Study of the BENEFIT Study (Betaferon / Betaseron in Newly Emerging Multiple Sclerosis for Initial Treatment) - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Interferon-ß-1b - Interferon -1b Treatment by Cyclical Administration - This study is currently recruiting patients (Current: 05 Jan 2006)
• Interferon-Beta 1A - Safety and Tolerability of Interferon-Beta-1a and Estroprogestins Association in MS Patients - This study is currently recruiting patients (Current: 05 Jan 2006)
• Interferon-beta-1a (Avonex) plus methylprednisolone - Avonex (Interferon-Beta-1a) and Avonex Plus Methylprednisolone for the Treatment of Relapsing-Remitting MS - This study has been completed (Current: 05 Jan 2006)
• Interferon-beta-1a FBS-free/HSA-free - Rebif New Formulation in Relapsing Forms of Multiple Sclerosis (RMS) - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Kemstro - A Multicenter, Open-Label Randomized Crossover Trial to Assess Subject Preference for Kemstro Compared to Conventional Baclofen Tablets in Subjects With Stable Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Lamotrigine - A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• MESNA - High Dose Chemo/Radiotherapy and Hematopoietic Stem Cell Transplant for Patients With Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006)
• MK0812 - A Study to Assess the Effects of MK-0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by MRI. - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Methotrexate - AVONEX Combination Trial ACT - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Methotrexate - Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Methotrexate - Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX Treatment, in Patients Presenting With a First Acute Demyelinating Event. - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Methylprednisolone (drug) - Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Methylprednisolone - Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX Treatment, in Patients Presenting With a First Acute Demyelinating Event. - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Methylprednisolone - Longitudinal Optic Neuritis Study (LONS) - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Methylprednisolone - Optic Neuritis Treatment Trial (ONTT) - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Methylprednisolone - Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Minocycline - Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline - This study is currently recruiting patients (Current: 05 Jan 2006)
• Mitoxantrone - A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis. - This study has been completed (Current: 05 Jan 2006)
• Mitoxantrone - A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Mitoxantrone - Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple Sclerosis - This study has been terminated (Current: 05 Jan 2006)
• Mitoxantrone - Study Evaluating Mitoxantrone in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Modafinil - Modafinil in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Monoclonal Antibody M-T412 - A Maintenance Extension of Phase I Pilot Study of Chimeric Anti-CD4 Antibody M-T412 in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Mycophenolate Mofetil (cellcept) - Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• N-acetylcysteine - Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine. - This study is currently recruiting patients (Current: 05 Jan 2006)
• NBI-5788 - Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS) - This study has been completed (Current: 05 Jan 2006)
• Natalizumab - Natalizumab in Combination With Glatiramer Acetate (GA) in Patients With Relapsing-Remitting Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Natalizumab - Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Natalizumab - Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Nomegestrol Acetate - POPART'MUS: Prevention of Post Partum Relapses With Progestin and Estradiol in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Novantrone(R) (mitoxantrone for injection concentrate) - Registry to Evaluate Novantrone (R) Effects in Worsening Multiple Sclerosis (RENEW) - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Placebo - Safety and Efficacy of Pravastatin in Relapsing-Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Pravastatin - Safety and Efficacy of Pravastatin in Relapsing-Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Prednisone - Longitudinal Optic Neuritis Study (LONS) - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Prednisone - Optic Neuritis Treatment Trial (ONTT) - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Prednisone - Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Provigil (modafinil) - Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS - This study is currently recruiting patients (Current: 05 Jan 2006)
• Provigil - Fatigue Treatment Using Provigil - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• RG2077 (CTLA4-IgG4m) - Safety of RG2077 in Patients With Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• RO0506997 - A Study in Multiple Sclerosis Patients to Determine the Safety of Different Doses of RO0506997 Compared to Placebo and Their Effects on Multiple Sclerosis Lesions - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Rebif/Lipitor - EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Rebif - Implementation Study of Treatment Optimization Recommendations on Relapsing-Remitting Multiple Sclerosis (RR MS) Subjects - This study has been terminated (Current: 05 Jan 2006)
• Rifampin - Antibiotic Treatment Trial Directed Against Chlamydia Pneumonia in Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Riluzole - Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia - This study is currently recruiting patients (Current: 05 Jan 2006)
• Rituxan (rituximab) - A Study to Evaluate Rituximab in Adults With Relapsing Remitting Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Rituxan (rituximab) - A Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Rolipram - Rolipram to Treat Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• SB683699 - Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Sativex - Use of Cannabinoids in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Simvastatin - A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Simvastatin - Simvastatin Treatment of Patients With Acute Optic Neuritis. - This study is not yet open for patient recruitment (Current: 05 Jan 2006)
• Sirolimus - Treating Multiple Sclerosis With Sirolimus, an Immune System Suppressor - This study has been completed (Current: 05 Jan 2006)
• Smoked Cannabis - Cannabis for Spasticity in Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Smoked Cannabis - Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Standard Gadolinium Contrast - Diagnostic Study of Quantitative Imaging and Spectroscopy in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Teriflunomide - Safety and Efficacy of Teriflunomide (HMR 1726) in Multiple Sclerosis With Relapses - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Teriflunomide - Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis - This study is currently recruiting patients (Current: 05 Jan 2006)
• Tizanidine Hydrochloride Capsule - Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity. - This study has been completed (Current: 05 Jan 2006)
• Vitamin E/Selenium - Natural Antioxidants in the Treatment of Multiple Sclerosis - This study has been completed (Current: 05 Jan 2006)
• Zenapax - Zenapax to Treat Multiple Sclerosis - This study is no longer recruiting patients (Current: 05 Jan 2006)
• Zyrtec (cetirizine hydrochloride) - A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec) or Placebo Prior to Daily Injections of Copaxone. - This study is currently recruiting patients (Current: 05 Jan 2006)

http://www.wrongdiagnosis.com/m/multiple_sclerosis/trials.htm